Form 4: BrightSpring CFO Phipps Exercises Options, Sells Shares, Gets New Grants

BrightSpring Health Services CFO Jennifer A. Phipps reported exercising stock options, selling shares, and receiving new equity grants in recent transactions.

Summary

• Jennifer A. Phipps, Chief Financial Officer of BrightSpring Health Services, Inc. (BTSG), reported multiple equity transactions on March 4 and 5, 2026.
• On March 4, 2026, Phipps exercised 35,000 stock options with an exercise price of $6.37 per share, acquiring 35,000 shares of common stock.
• Concurrently on March 4, 2026, Phipps sold 35,000 shares of common stock at a price of $41.15 per share through a registered public offering.
• Also on March 4, 2026, 35,331 performance-based stock options (2019 Performance Options with a $6.37 exercise price) and 5,888 performance-based stock options (2020 Performance Options with a $7.01 exercise price) fully vested.
• On March 5, 2026, Phipps was granted 53,384 Restricted Stock Units (RSUs) and 130,860 new stock options with an exercise price of $41.77.
• The newly granted RSUs and stock options are scheduled to vest in three equal annual installments commencing on January 25, 2027.
• Following these reported transactions, Phipps' direct beneficial ownership of common stock increased to 250,224 shares.

Sentiment

Score: 6

Explanation: StockSavvy.ai views this as a neutral to slightly positive filing. While there is an insider sale, it is offset by significant new equity grants and the vesting of performance-based options, indicating continued alignment and future incentive. The sale was also part of a public offering, suggesting a planned liquidity event rather than a sudden divestment.

Positives

• The vesting of 35,331 performance-based stock options (2019 Performance Options) and 5,888 performance-based stock options (2020 Performance Options) indicates the successful achievement of prior performance conditions.
• The grant of 53,384 Restricted Stock Units (RSUs) and 130,860 new stock options demonstrates continued equity compensation and aligns the CFO's incentives with future company performance.
• The sale of shares at $41.15, significantly above the exercise price of $6.37, indicates a substantial personal gain for the Chief Financial Officer from previously awarded equity.

Negatives

• The sale of 35,000 shares of common stock by the Chief Financial Officer, even if part of a pre-arranged plan, represents a reduction in direct equity exposure.

Future Outlook

The newly granted Restricted Stock Units and stock options are structured to vest in three equal annual installments commencing on January 25, 2027, indicating future equity compensation and long-term incentive alignment.

Industry Context

StockSavvy.ai notes that equity compensation, including stock options and restricted stock units, is a standard practice in the healthcare services industry to align executive incentives with shareholder value. The exercise and sale of options, often coupled with new grants, is a common pattern for executives managing their personal equity holdings and compensation.

Comparison to Industry Standards

• StockSavvy.ai notes that the structure of performance-based options and multi-year vesting schedules for new grants aligns with typical executive compensation packages in large publicly traded healthcare companies, such as those seen at competitors like Encompass Health Corporation or LHC Group.
• The significant spread between the exercise price ($6.37) and sale price ($41.15) for the exercised options reflects a substantial return on previously granted equity, which is a common outcome for executives in successful growth companies.

Related Party Transactions

• The transactions involve Jennifer A. Phipps, the Chief Financial Officer, exercising stock options, selling shares, and receiving new equity grants from BrightSpring Health Services, Inc., which are standard related-party compensation and liquidity events for an executive.

Stakeholder Impact

• Shareholders: The sale of shares by a CFO could be viewed with slight caution, but the new grants demonstrate continued executive commitment. The public offering itself could increase liquidity.
• Employees: No direct impact mentioned.
• Customers: No direct impact mentioned.
• Suppliers: No direct impact mentioned.
• Creditors: No direct impact mentioned.

Next Steps

• The newly granted Restricted Stock Units and stock options will begin vesting in three equal annual installments commencing on January 25, 2027.

Key Dates

Keywords

BrightSpring Health Services, BTSG, Jennifer A Phipps, CFO, Form 4, insider transaction, stock options, restricted stock units, RSU, equity compensation, stock sale, vesting, beneficial ownership